New drug aims to shield heart muscle after major attack
Disease control
Recruiting now
This study tests an experimental drug called RTP-026 in 96 adults who have had a severe type of heart attack (STEMI). Participants receive three short infusions of the drug or a placebo. The goal is to see if RTP-026 can reduce heart muscle damage, measured by blood markers. The …
Phase: PHASE2 • Sponsor: ResoTher Pharma • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC